Professor Flynn explains why dossiers originally submitted under article 13.1 of the health claims regulation may fare better under article 13.5, where NDA-applicant dialogue potential is greater.
“Many of the claims on the article 13 list could easily have been submitted also as applications under article 13.5 and indeed quite a number of them were,” Professor Flynn said.